Difference between pathogenic and inhibitory bacterial florae is associated with acute exacerbation of idiopathic pulmonary fibrosis

S. Ohshimo (Hiroshima, Japan), H. Nishi (Hiroshima, Japan), K. Yamaguchi (Hiroshima, Japan), Y. Horimasu (Hiroshima, Japan), T. Masuda (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), K. Fujitaka (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), H. Kawaguchi (Hiroshima, Japan), F. Bonella (Essen, Germany), J. Guzman (Bochum, Germany), U. Costabel (Essen, Germany), N. Hattori (Hiroshima, Japan), N. Shime (Hiroshima, Japan)

Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session: Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 826
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ohshimo (Hiroshima, Japan), H. Nishi (Hiroshima, Japan), K. Yamaguchi (Hiroshima, Japan), Y. Horimasu (Hiroshima, Japan), T. Masuda (Hiroshima, Japan), S. Miyamoto (Hiroshima, Japan), H. Iwamoto (Hiroshima, Japan), K. Fujitaka (Hiroshima, Japan), H. Hamada (Hiroshima, Japan), H. Kawaguchi (Hiroshima, Japan), F. Bonella (Essen, Germany), J. Guzman (Bochum, Germany), U. Costabel (Essen, Germany), N. Hattori (Hiroshima, Japan), N. Shime (Hiroshima, Japan). Difference between pathogenic and inhibitory bacterial florae is associated with acute exacerbation of idiopathic pulmonary fibrosis. 826

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Imbalance in the oral bacterial flora as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019




The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019



Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (2) 00036-2016; 10.1183/23120541.00036-2016
Year: 2017



Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Tumor-associated antigens in acute exacerbation of idiopathic pulmonary fibrosis: Associations with disease activity
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010

Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 566s
Year: 2003

Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019

Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 576s
Year: 2006

Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Year: 2017



Acute exacerbation of idiopathic pulmonary fibrosis
Source: Eur Respir J 2004; 23: 792
Year: 2004


Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence?
Source: Eur Respir J 2002; 19: 387-389
Year: 2002


Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Source: Eur Respir J 2002; 20: 9S-19S
Year: 2002



The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020

Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
Source: Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020
Year: 2020



Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm
Source: Eur Respir J 2015; 46: 512-520
Year: 2015



The role of chlamydia pneumoniae infection in acute purulent exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 221s
Year: 2002

Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011